Natera

• NCT07340567

  Collaborator, Phase 3, Active, not recruiting, 2,450 people, 14 Jan 2026

• AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas

  Collaborator, Phase 2, Recruiting, 242 people, 18 Dec 2025

• NCT07021989

  Collaborator, Phase 2, Recruiting, 38 people, 15 Jun 2025

• Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

  Collaborator, Phase 2, Recruiting, 250 people, 15 Jul 2024

• Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)

  Collaborator, Phase 3, Recruiting, 220 people, 23 Aug 2022

• NCT04703101

  Collaborator, Phase 1, Recruiting, 25 people, 11 Jan 2021

Sources: clinicaltrials.gov

• MGUS in Black individuals in Soweto, South Africa screened by mass spectrometry: results of the PROMISE South Africa study

  Consulting or advice, Board or leadership role, 2 Oct 2026

• Recommendations of the American Cancer Society workshop on design, conduct, analysis, and reporting of multicancer early detection trials with late-stage incidence end points and post-trial ongoing evaluation-The Peachtree Consensus

  Consulting or advice, Fees or honoraria, 1 Oct 2026

• Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer

  Fees or honoraria, 24 Sept 2026

• Proteomic signatures during pregnancy: an exploratory cohort study of long-term health indicators

  Grants or research support, 22 Sept 2026

• Performance and safety of a multi-cancer early detection test: the PATHFINDER 2 study

  Fees or honoraria, 22 Sept 2026

• Heart Transplantation in 2076: Evolution, Transformation, or Obsolescence?

  Consulting or advice, Fees or honoraria, 1 Sept 2026

• Frailty Patterns, Reversibility, and Outcomes With a Magnetically Levitated Left Ventricular Assist Device

  Consulting or advice, Fees or honoraria, 1 Sept 2026

• Performance-based frailty tools capture distinct risk phenotypes in kidney transplant candidates: A comparative analysis of the FRAIL scale and short physical performance battery

  Grants or research support, 25 Aug 2026

• Association between rheumatoid arthritis, frailty status, mortality and anti-cancer therapy: a retrospective SEER-Medicare analysis in patients with non-metastatic renal cell carcinoma

  Consulting or advice, Fees or honoraria, 11 Aug 2026

• Multi-population GWAS meta-analysis identifies bladder cancer susceptibility loci and highlights genetic regulation of smoking-related risk

  Grants or research support, 8 Aug 2026

• Association of sodium-glucose co-transport protein 2 inhibitor use with clinical outcomes in patients receiving immune checkpoint inhibitors: a pan-tumor propensity-matched analysis

  Consulting or advice, Fees or honoraria, 6 Aug 2026

• Comparative environmental impact analysis of screening tests for colorectal cancer: a single-centre life cycle assessment

  Fees or honoraria, 4 Aug 2026

• Novel Blood-Based Tests for Colorectal Cancer Screening

  Consulting or advice, 8 Apr 2026

• Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer

  Fees or honoraria, 4 Mar 2026

• Anti-uPAR CAR T cells reverse and prevent aging-associated defects in intestinal regeneration and fitness

  Fees or honoraria, 25 Nov 2025

• The intracellular and extracellular fate of DNA and chromatin from micronuclei determines their pathogenicity

  Employment, 2 Sept 2025

Sources: pubmed.ncbi.nlm.nih.gov